Ovalicin attenuates atopic dermatitis symptoms by inhibiting IL-31 signaling and intracellular calcium influx

被引:3
作者
Hwang, Sung-Hyun [1 ,2 ]
Yang, Yeseul [1 ,2 ]
Jeong, Yeji [1 ,2 ]
Kim, Yongbaek [1 ,3 ]
机构
[1] Seoul Natl Univ, Coll Vet Med, Lab Clin Pathol, 1 Gwanak Ro, Seoul 08826, South Korea
[2] Seoul Natl Univ, Coll Vet Med, Brain Korea 21 Future Vet Med Leading Educ & Res, Seoul 08826, South Korea
[3] Seoul Natl Univ, Coll Vet Med, Res Inst Vet Sci, Seoul 08826, South Korea
来源
JOURNAL OF BIOMEDICAL RESEARCH | 2021年 / 35卷 / 06期
基金
新加坡国家研究基金会;
关键词
ovalicin; IL-31; pruritus; inflammation; calcium; atopic dermatitis; ITCH; INVOLVEMENT; ACTIVATION; THERAPIES; PRURITUS; TRPV1;
D O I
10.7555/JBR.35.20210012
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Atopic dermatitis (AD) is a common skin disorder difficult to be treated with medication. This study investigated the potential of ovalicin extracted from Cordyceps militaris for the treatment of AD using in vitro and in vivo models. We found that, in canine macrophage cell line DH82, lipopolysaccharide (LPS) upregulated the expression of genes associated with inflammation and pruritic responses through activating calcium and interleukin-31 (IL-31) signaling, and the upregulation could be suppressed by ovalicin, with an effect significantly stronger than dexamethasone. Ovalicin also reduced the expression of IL-31 downstream genes, including JAK2 (Janus kinase 2), TRPV1 (transient receptor potential vanilloid receptor-1), and HRH2 (histamine receptor H2). Ovalicin significantly alleviated the allergic symptoms in the AD mouse model. Histologically, the number of macrophages and mast cells infiltrated in the dermis was significantly reduced by ovalicin treatment. In the skin tissue of AD mice, reduction of IL-31 receptor was observed in the ovalicin treated group compared to the group without ovalicin treatment. To our knowledge, this is the first study to elucidate the anti-atopic mechanism of ovalicin, which could be an alternative to steroidal drugs commonly used for AD treatment.
引用
收藏
页码:448 / 458
页数:12
相关论文
共 35 条
[31]   A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis [J].
Michels, Gina M. ;
Ramsey, Deborah S. ;
Walsh, Kelly F. ;
Martinon, Olivier M. ;
Mahabir, Sean P. ;
Hoevers, Jacquelien D. ;
Walters, Rodney R. ;
Dunham, Steven A. .
VETERINARY DERMATOLOGY, 2016, 27 (06) :478-+
[32]   House dust mite allergens Der f and Der p induce IL-31 production by blood-derived T cells from atopic dermatitis patients [J].
Szegedi, Krisztina ;
van Lier, Amanda ;
Res, Pieter C. ;
Chielie, Saskia ;
Bos, Jan D. ;
Kezic, Sanja ;
Middelkamp-Hup, Maritza A. ;
Luiten, Rosalie M. .
EXPERIMENTAL DERMATOLOGY, 2018, 27 (04) :393-395
[33]   Soybean Fermented with Bacillus amyloliquefaciens (Cheonggukjang) Ameliorates Atopic Dermatitis-Like Skin Lesion in Mice by Suppressing Infiltration of Mast Cells and Production of IL-31 Cytokine [J].
Cho, Byoung Ok ;
Shin, Jae Young ;
Kim, Ji-su ;
Che, Denis Nchang ;
Kang, Hyun Ju ;
Jeong, Do-Youn ;
Jang, Seon Il .
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2019, 29 (05) :827-837
[34]   Moringa concanensis L. Alleviates DNCB-Induced Atopic Dermatitis-like Symptoms by Inhibiting NLRP3 Inflammasome-Mediated IL-1β in BALB/c Mice [J].
Kim, Kyeong-Min ;
Kim, So-Yeon ;
Mony, Tamanna Jahan ;
Bae, Ho Jung ;
Choi, Seung-Hyuk ;
Choi, Yu-Yeong ;
An, Ju-Yeon ;
Kim, Hyun-Jeong ;
Cho, Ye Eun ;
Sowndhararajan, Kandhasamy ;
Park, Se Jin .
PHARMACEUTICALS, 2022, 15 (10)
[35]   PeiTuQingXin formula alleviated atopic dermatitis symptoms via inhibiting TRADD/TRAF2/RIP1 complex mediated NF-κB signaling pathway activation [J].
Cheng, Zixuan ;
Ma, Xin ;
Luo, Feng ;
Mo, Xiumei ;
Liu, Junfeng ;
Chen, Dachan ;
Yan, Fenggen .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)